precancerous lesion of gastric cancer
Conditions
Interventions
The treatment group:Shenci Formula
Sponsors
Guangdong Provincial Hospital of Chinese Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) Patients with chronic gastritis in the diagnosis of Western medicine combined with atrophy, intestinal metaplasia or dysplasia; (2) Patients with TCM syndrome type of spleen deficiency and phlegm stasis; (3) Patients improved gastroscopy and pathological examination within a month; (4) Patients age ranged from 18 to 70 years; (5) Patients who voluntarily signed the informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with severe dysplasia of gastric mucosa, gastric cancer or other malignancies were diagnosed or suspected; (2) Patients with serious primary diseases such as heart, brain, liver, kidney, endocrinology and blood were combined; (3) Patients with mental disorders; (4) Women in pregnancy and lactation; (5) Patients who have previously been allergic to the tested drugs or their components; (6) Patients had accepted treatments, which may affect the indicators of effectiveness and safety; (7) Patients combined with other digestive tract diseases; (8) Patients reexamination of HP is positive after the introduction of the treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| total effective rate of overall efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| total effective rate of treatment in atrophy of gastric mucosa;total effective rate of treatment in intestinal metaplasia of gastric mucosa;total effective rate of treatment in intraepithelial neoplasia of gastric mucosa; | — |
Countries
China
Contacts
Public ContactGengxin Chen
Guangdong Provincial Hospital of Chinese Medicine
Outcome results
None listed